Stay updated on Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Publications section updated to clarify that publications are provided voluntarily by contributors who enter information about the study results, and the site revision badges were updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-26T13:47:37.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Publications section updated: a 2014 NEJM paper on CTLA-4 blockade was added with erratum details, and the previous citation entry was removed.
    Difference
    0.4%
    Check dated 2025-11-19T08:17:42.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The two screenshots show the same Study Details page with identical trial information (title, conditions, eligibility criteria, interventions, outcomes, and locations). No core content or data elements were added or removed.
    Difference
    0.4%
    Check dated 2025-10-28T05:18:54.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    - Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. The page now communicates operating status details and a newer software version.
    Difference
    2%
    Check dated 2025-10-06T16:07:14.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; core page metadata updated to reflect a new release.
    Difference
    0.0%
    Check dated 2025-09-29T10:06:28.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed; this suggests minor updates and a small UI tweak, with no evident changes to core content.
    Difference
    0.1%
    Check dated 2025-09-15T00:25:48.000Z thumbnail image

Stay in the know with updates to Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.